Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Sponsor

Casa Di Cura Accreditata Istituto Chirurgico Ortopedico Traumatologico Marco Pasquali

Italy Via Franco Faggiana 1668, 04100 Latina, Italy

About the sponsor

Clinical research activity is centred on cardiovascular risk and platelet reactivity, with interest in patients receiving antiplatelet therapy and those with established cardiovascular disease.

  • Platelet function
  • Aspirin and clopidogrel
  • High-risk cardiovascular patients

The sponsor’s work reflects a focus on cardiovascular complications linked to metabolic disease and treatment response in patients with elevated thrombotic risk.

About Specializations

Casa Di Cura Accreditata Istituto Chirurgico Ortopedico Traumatologico Marco Pasquali runs clinical trials in conditions such as Type 2 diabetes mellitus, Obesity, Overweight, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

1 clinical trial

Type 2 diabetes mellitus+2

Not yet recruiting

Effect of semaglutide, acetylsalicylic acid, and clopidogrel on blood clotting in patients with diabetes or overweight with cardiovascular disease

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Casa Di Cura Accreditata Istituto Chirurgico Ortopedico Traumatologico Marco Pasquali

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.